Large-scale testing (Phase 3)Looking for participantsNCT05760378
What this trial is testing
Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.
Who this might be right for
Triple-Negative Breast Cancer
Fudan University 223